BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 6192269)

  • 1. [Tumor marker in urology].
    Shimazaki J; Ito H; Miyauchi T; Maruoka M; Isaka S; Masukagami T; Ando K
    Gan No Rinsho; 1983 May; 29(6):684-92. PubMed ID: 6192269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic progress in testicular carcinoma].
    Aiginger P; Kolbe H; Kühböck J; Spona J
    Acta Med Austriaca; 1978; 5(4-5):159-61. PubMed ID: 91300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of biologic tumor markers in testicular cancer.
    Javadpour N
    Cancer Treat Rep; 1979; 63(9-10):1643-7. PubMed ID: 91433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemical determination of human chorionic gonadotropin and alpha-fetoprotein in sera and tumors of patients with testicular cancer.
    Javadpour N; McIntire KR; Waldmann TA
    Natl Cancer Inst Monogr; 1978 Dec; (49):209-13. PubMed ID: 86162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of serum ferritin level in testicular tumors].
    Takai K; Kojima H; Kume H; Takemura T; Moriyama N; Murahashi I; Aso Y
    Hinyokika Kiyo; 1991 Apr; 37(4):357-62. PubMed ID: 1716405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
    Lange PH
    Natl Cancer Inst Monogr; 1978 Dec; (49):215-7. PubMed ID: 86163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor markers in patients with non-seminomatous germ cell tumors of the testis.
    Willemse PH; Sleijfer DT; Schraffordt Koops H; De Bruijn HW; Oosterhuis JW; Brouwers TM; Ockhuizen T; Marrink J
    Oncodev Biol Med; 1981; 2(1-2):117-28. PubMed ID: 6170952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor markers in urology.
    Grossman HB
    Semin Urol; 1985 Feb; 3(1):10-7. PubMed ID: 2408306
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biological markers and germinal tumors of the testis. Value and limitations of the assay of chorionic gonadotrophin hormone and alpha-fetoprotein].
    Bassoulet J; Pabot du Chatelard P; Ricordel I; Auberget JL; Guillemot MC; Merrer J; Timbal Y
    J Urol (Paris); 1988; 94(8):393-6. PubMed ID: 2467947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metastasis and markers].
    Trinchieri A; Rovera F; Longo G; Del Nero A; Zanetti G; Austoni E
    Arch Ital Urol Nefrol Androl; 1992 Mar; 64(1):27-30. PubMed ID: 1373913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of biologic tumor markers in testicular cancer.
    Javadpour N
    Cancer; 1980 Apr; 45(7 Suppl):1755-61. PubMed ID: 6154517
    [No Abstract]   [Full Text] [Related]  

  • 12. Lactic dehydrogenase in the monitoring and prognosis of testicular cancer.
    Lippert MC; Javadpour N
    Cancer; 1981 Nov; 48(10):2274-8. PubMed ID: 6170417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of serum AFP, HCG, and CEA in testicular tumor].
    Miki T; Oda H; Kamei O; Saiki S; Kinouchi T; Kuroda M; Yoshida M; Kiyohara H; Usami M; Osafune M
    Nihon Hinyokika Gakkai Zasshi; 1983 Jul; 74(7):1236-47. PubMed ID: 6198548
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study of various markers (alpha fetoprotein, chorionic gonadotropin, lactate dehydrogenase) during chemotherapy of malignant testicular tumors].
    Lichinitser MR; Bassalyk LS; Levina DM; Pashintseva LP; Molodyk AA
    Ter Arkh; 1984; 56(6):77-9. PubMed ID: 6206585
    [No Abstract]   [Full Text] [Related]  

  • 15. [Significance of tumor markers in the treatment of urological malignancies].
    Akaza H; Kameyama S; Aso Y
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3034-40. PubMed ID: 2445294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor markers in germ cell tumors. Clinical use and research aspects].
    Clausen PP; Nørgaard-Pedersen B; Arends J; Ingild A; Jacobsen GK; Jacobsen M; Juhl BR; Kjaersgaard E; Nissen MH; Schultz-Larsen P; Toftager-Larsen K; Zeuthen J
    Ugeskr Laeger; 1982 May; 144(18):1285-90. PubMed ID: 6181594
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tumor markers in gynecologic malignancies].
    Tojo S; Suzuki A; Fujii S; Ashitaka Y; Maruo T; Matsuura S
    Gan No Rinsho; 1983 May; 29(6):678-83. PubMed ID: 6192268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of alpha-fetoprotein and beta-HCG in testis tumor patients.
    Dunzendorfer U; Jurincic C
    Urol Int; 1987; 42(4):248-53. PubMed ID: 2445089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
    Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A
    Oncology; 1983; 40(1):1-10. PubMed ID: 6185897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of serial measurement of both human chorionic gonadotropin and alpha-fetoprotein for monitoring germinal cell tumors.
    Perlin E; Engeler JE; Edson M; Karp D; McIntire KR; Waldmann TA
    Cancer; 1976 Jan; 37(1):215-9. PubMed ID: 55299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.